The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The clinical utility of a circulating tumor cell based cerebrospinal fluid assay in the diagnosis and molecular analysis of leptomeningeal disease in patients with metastatic non-small cell lung cancer.
 
Ramya Muddasani
Stock and Other Ownership Interests - Abbvie; Abbvie; Actinium Pharmaceuticals; Actinium Pharmaceuticals (I); Advaxis (I); Agenus; Agenus (I); Aprea Therapeutics; Aprea Therapeutics (I); Athenex (I); AVEO (I); Cellectar; Cellectar (I); crispr therapeutics (I); Curis (I); DelMar Pharmaceuticals; DelMar Pharmaceuticals (I); DelMar Pharmaceuticals (I); Epizyme; Epizyme (I); Forty Seven; Forty Seven (I); Gritstone Bio (I); Heat Biologics (I); Immunomedics; Immunomedics (I); Mereo BioPharma (I); NantHealth (I); NantKwest,; NantKwest, (I); Novavax (I); Onconova Therapeutics; Onconova Therapeutics (I); Pfizer (I); Portola Pharmaceuticals (I); Vaxart
 
Amanda Reyes
No Relationships to Disclose
 
Jeremy Fricke
No Relationships to Disclose
 
Isa Mambetsariev
No Relationships to Disclose
 
Erminia Massarelli
Honoraria - AstraZeneca; Physicans' Education Resource
Consulting or Advisory Role - Abbvie; Bristol Myers Squibb Foundation; Daiichi-Sankyo; Fusion Pharmaceuticals; Gilead Sciences; Iovance Biotherapeutics; Janssen Scientific Affairs; Mirati Therapeutics; Sanofi
Travel, Accommodations, Expenses - Physicans' Education Resource
 
Michelle Afkhami
No Relationships to Disclose
 
Ravi Salgia
No Relationships to Disclose
 
Jyoti Malhotra
Consulting or Advisory Role - Abbvie; AstraZeneca; BioAtla; Bristol Myers Squibb Foundation; Catalyst Pharmaceuticals; Daiichi Sankyo/Astra Zeneca; Janssen Oncology; Mirati Therapeutics; OncoCyte; Regeneron; Sanofi; Takeda
Speakers' Bureau - Tempus
Research Funding - BeyondSpring Pharmaceuticals (Inst); Biohaven Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Daiichi Sankyo (Inst)